These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypes. Saeui CT; Nairn AV; Galizzi M; Douville C; Gowda P; Park M; Dharmarha V; Shah SR; Clarke A; Austin M; Moremen KW; Yarema KJ PLoS One; 2018; 13(5):e0195812. PubMed ID: 29847599 [TBL] [Abstract][Full Text] [Related]
4. A novel sugar analog enhances sialic acid production and biotherapeutic sialylation in CHO cells. Yin B; Wang Q; Chung CY; Bhattacharya R; Ren X; Tang J; Yarema KJ; Betenbaugh MJ Biotechnol Bioeng; 2017 Aug; 114(8):1899-1902. PubMed ID: 28295160 [TBL] [Abstract][Full Text] [Related]
5. Combining Butyrated ManNAc with Glycoengineered CHO Cells Improves EPO Glycan Quality and Production. Wang Q; Chung CY; Yang W; Yang G; Chough S; Chen Y; Yin B; Bhattacharya R; Hu Y; Saeui CT; Yarema KJ; Betenbaugh MJ; Zhang H Biotechnol J; 2019 Apr; 14(4):e1800186. PubMed ID: 30221828 [TBL] [Abstract][Full Text] [Related]
7. Targeting pro-invasive oncogenes with short chain fatty acid-hexosamine analogues inhibits the mobility of metastatic MDA-MB-231 breast cancer cells. Campbell CT; Aich U; Weier CA; Wang JJ; Choi SS; Wen MM; Maisel K; Sampathkumar SG; Yarema KJ J Med Chem; 2008 Dec; 51(24):8135-47. PubMed ID: 19053749 [TBL] [Abstract][Full Text] [Related]
8. Extracellular and intracellular esterase processing of SCFA-hexosamine analogs: implications for metabolic glycoengineering and drug delivery. Mathew MP; Tan E; Shah S; Bhattacharya R; Adam Meledeo M; Huang J; Espinoza FA; Yarema KJ Bioorg Med Chem Lett; 2012 Nov; 22(22):6929-33. PubMed ID: 23041156 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the cellular uptake and metabolic conversion of acetylated N-acetylmannosamine (ManNAc) analogues to sialic acids. Jones MB; Teng H; Rhee JK; Lahar N; Baskaran G; Yarema KJ Biotechnol Bioeng; 2004 Feb; 85(4):394-405. PubMed ID: 14755557 [TBL] [Abstract][Full Text] [Related]
10. Metabolic Glycoengineering with Azide- and Alkene-Modified Hexosamines: Quantification of Sialic Acid Levels. Dold JEGA; Wittmann V Chembiochem; 2021 Apr; 22(7):1243-1251. PubMed ID: 33180370 [TBL] [Abstract][Full Text] [Related]
11. Characterization of ligand binding to the bifunctional key enzyme in the sialic acid biosynthesis by NMR: II. Investigation of the ManNAc kinase functionality. Benie AJ; Blume A; Schmidt RR; Reutter W; Hinderlich S; Peters T J Biol Chem; 2004 Dec; 279(53):55722-7. PubMed ID: 15498763 [TBL] [Abstract][Full Text] [Related]
12. Chronic administration of N-acetyl-D-mannosamine improves age-associated impairment of long-term potentiation in the senescence-accelerated mouse. Taniguchi S; Kuwahara M; Ito K Neurosci Lett; 2015 Jun; 598():41-6. PubMed ID: 25962821 [TBL] [Abstract][Full Text] [Related]
13. Glycoengineering of Esterase Activity through Metabolic Flux-Based Modulation of Sialic Acid. Mathew MP; Tan E; Labonte JW; Shah S; Saeui CT; Liu L; Bhattacharya R; Bovonratwet P; Gray JJ; Yarema KJ Chembiochem; 2017 Jul; 18(13):1204-1215. PubMed ID: 28218815 [TBL] [Abstract][Full Text] [Related]